Company: VERA
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001140361-25-012034
Chunk: 61

Company: Vera Therapeutics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 61
---
 31, 2024. Our Board adopted a non-employee director compensation policy in May 2021 that is applicable to all of our non-employee directors. Under our non-employee director compensation policy in effect as of January 1, 2024 each non-employee director will receive the following compensation for service on our Board:

| • | an annual cash retainer of $40,000; and an additional annual cash retainer of $30,000 for services as non-executive chair of our Board (the “Chair Retainer”); |

| • | an additional annual cash retainer of $10,000, $6,000 and $5,000 for service as a member of the Audit Committee, Compensation Committee and the Nominating Committee, respectively (the “Committee Member Retainer”); |

| • | an additional annual cash retainer of $10,000, $6,000 and $5,000 for service as chair of the Audit Committee, Compensation Committee and the Nominating Committee, respectively (the “Committee Chair Retainer”); |

| • | an initial option grant to purchase 40,000 shares of our Class A common stock on the date of each such non-employee director’s appointment to our Board (the “Initial Grant”); and |

| • | an annual option grant to purchase 20,000 shares of our Class A common stock on the date of each of our annual stockholder meetings (the “Annual Grant”), for non-employee directors who joined our Board no later than February 28 of the year in which the stockholders meeting is held. |

On May 2, 2024, the Board amended the non-employee director compensation policy, effective as of May 2, 2024, to reduce the size of the Initial Grant and Annual Grant as set forth below:

| • | the Initial Grant was amended to provide for the lesser of (i) 25,000 shares of our Class A common stock and (ii) the maximum number of shares of our Class A common stock that would result in the option having a grant-date fair value of not more than $700,000, on the date of each such non-employee director’s appointment to our Board; and |

| • | the Annual Grant was amended to provide for the lesser of (i) 14,000 shares of our Class A common stock and (ii) the maximum number of shares of our Class A common stock that would result in the option having a